RXTransparent is an end-to-end compliance solution that provides visibility and transparency throughout the entire healthcare supply chain, including traceability from loading dock to dose. Using cloud-based technology, RXTransparent provides pedigree tracking, including capabilities for product transfers, borrow and trade, and repackaging/off-label use as well as reporting. On February 11th, 2020, RXTransparent was acquired by Inmar, terms of the agreement were not disclosed.
Missing: RXTransparent's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: RXTransparent's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing RXTransparent
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
RXTransparent is included in 3 Expert Collections, including Regtech.
Technology that addresses regulatory challenges and facilitates the delivery of compliance requirements in FIs. Regulatory technology helps FIs and regulators address challenges ranging from traditional compliance and risk management to data reporting and transmission.
Supply Chain & Logistics Tech
Companies offering technology-driven solutions that serve the supply chain & logistics space (e.g. shipping, inventory mgmt, last mile, trucking).
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Latest RXTransparent News
Feb 11, 2020
Provides additional support for pharmacy clients to remain compliant with new industry regulations | Source: Inmar, Inc. Winston-Salem, NC, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Inmar Intelligence announced today that it has acquired Forerunner Holdings Inc., the developers of RXTransparent, an SAAS platform allowing healthcare providers to put their finger on the pulse of drug supply chain through product inventory transparency, regulatory compliance and supply chain analytics. The acquisition brings with it two solutions that will support Inmar Intelligence’s pharmacy clients to make pharmacy operations more efficient and compliant with two recent industry regulations: DSCSA and USP <800>. The DSCSA Pharmacy Compliance solution from RXTransparent is a cloud-based, highly secure and scalable subscription service that streamlines product tracing, optimizes transactional transparency and makes incident reporting of counterfeit, suspect or stolen product effortless with minimal impact on daily pharmacy operations. The USP <800> Pharmacy Compliance solution includes a proprietary database of every hazardous drug listed on the NIOSH tables. Using this, Inmar Intelligence clients will be able to quickly create an Assessment of Risk (AOR) that identifies any hazardous drug in their facility and develop safe handling practices to protect healthcare workers against the long-term repercussions of exposure to these drugs. When used in conjunction with the DSCSA solution, it provides continuous monitoring of purchases, alerts clients if a new hazardous drug enters a formulary and adds the drug to the AOR. “Achieving compliance within the healthcare industry is only getting more urgent and failure to comply is not an option,” said David Mounts, Chairman and CEO of Inmar Intelligence. “Adding RXTransparent’s pharmacy compliance solutions to our already powerful healthcare platform provides our clients with an unmatched level of support to achieve and maintain compliance while saving time and protecting their staff, patients and facility.” Inmar Intelligence works with 85 percent of all hospitals and drug manufacturers and over 50,000 pharmacies in the United States. “By combining forces with Inmar Intelligence, RXTransparent will not only be able to secure U.S. drug supply chain and healthcare workers from hazardous drugs, but we can now unlock the potential for broader synergies and innovations across the entire US healthcare pharmacy supply chain,” said Dwight deVera, Sr. Director, Product Strategy at Inmar Intelligence. For more information about Inmar Intelligence’s healthcare platform and Innovator Ecosystem, please visit https://inmar.com/solutions-healthcare . ### Commerce Accelerated.™ Inmar Intelligence helps leading Fortune 500 companies and emerging brands stay relevant and propel growth while providing their consumers with personalized and precision-driven tools to save money, improve health and safety, and more conveniently go about their lives. Inmar Intelligence’s holistic portfolio of media products enables advertisers to access a variety of intelligent tools, including its influencer media platform, conversational commerce (chat-based media), audience extension and on-site digital media for retail. As a trusted intermediary for over 35 years, Inmar Intelligence has served retailers, manufacturers, healthcare providers, government and employers as their trusted intermediary and helped them redefine innovation. For more information about Inmar, please follow Inmar on Twitter , LinkedIn or Facebook , or call (866) 440-6917. Inmar has unmatched access to billions of consumer and business transactions in real-time. Holly PavlikaInmar, Inc.(336) firstname.lastname@example.org
RXTransparent Frequently Asked Questions (FAQ)
Where is RXTransparent's headquarters?
RXTransparent's headquarters is located at 1150 First Avenue, King Of Prussia.
What is RXTransparent's latest funding round?
RXTransparent's latest funding round is Acquired.
Who are the investors of RXTransparent?
Investors of RXTransparent include Inmar.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.